Bellinda L. King‐Kallimanis

Author

United States Food and Drug Administration ORCID

Also Known As

Alger, Emily, B. King-Kallimanis, B. King-kallimanis, B. L. King-Kallimanis, B.L. King-Kallimanis, Bellinda King-Kallimanis, Bellinda King‐Kallimanis, Bellinda L King-Kallimanis, Bellinda L. King-Kallimanis, Bellinda L. King‐Kallimanis

136

Publications

3.7K

Citations

H-Index

100

Concepts

All Affiliations

United States Food and Drug Administration Trinity College Dublin Center for Drug Evaluation and Research University of Amsterdam University of South Florida

About

Bellinda L. King‐Kallimanis is an author at United States Food and Drug Administration specializing in medicine, geriatrics, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	1.3K
2	Health Sciences	7	7	568
3	Public Health	6	6	534
4	Education	1	1	21
5	Nursing	1	1	13

Bellinda L. King‐Kallimanis

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of Mood, Anxiety, and Substance-Abuse Disorders for Older Americans in the National Comorbidity Survey-Replication Amber M. Gum, Bellinda L. King‐Kallimanis, Robert Kohn American Journal of Geriatric Psychiatry Mental DisordersSubstance AbuseSubstance UseHealth SciencesPsychiatry	2009	352
Screening and Brief Intervention for Substance Misuse Among Older Adults: The Florida BRITE Project Lawrence Schonfeld, Bellinda L. King‐Kallimanis, Darran M. Duchene, American Journal of Public Health	2009	196
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1 Preeti Narayan, Sakar Wahby, Jennifer Gao, Clinical Cancer Research Breast OncologyImmunologyPathologyPharmacotherapyImmunotherapeutics	2020	164
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer Preeti Narayan, Tatiana M. Prowell, Jennifer Gao, Clinical Cancer Research	2020	157
Negative perceptions of aging predict longitudinal decline in cognitive function. Deirdre A. Robertson, Bellinda L. King‐Kallimanis, Rose Anne Kenny Psychology and Aging Negative PerceptionsCognitive ScienceAgingPsychiatryHealthy Aging	2015	139
Measuring frailty using self-report and test-based health measures Olga Theou, Matthew O’Connell, Bellinda L. King‐Kallimanis, Age and Ageing	2015	137
Comorbidity of Depressive and Anxiety Disorders for Older Americans in the National Comorbidity Survey-Replication Bellinda L. King‐Kallimanis, Amber M. Gum, Robert Kohn American Journal of Geriatric Psychiatry Mental DisordersGeriatric PsychiatryPsychological Co-morbiditiesPsychiatryGeriatrics	2009	137
A bidimensional model of acculturation for Korean American older adults Yuri Jang, Giyeon Kim, David A. Chiriboga, Journal of Aging Studies AgingGeriatricsLongevitySociologyGlobal Aging	2007	127
Measurement Error, Reliability, and Minimum Detectable Change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among Community Living Middle-Aged and Older Adults Joanne Feeney, George M. Savva, Claire O’Regan, Journal of Alzheimer s Disease	2016	115
Development of the Brief Ageing Perceptions Questionnaire (B-APQ): a confirmatory factor analysis approach to item reduction Eithne Sexton, Bellinda L. King‐Kallimanis, Kàren Morgan, BMC Geriatrics	2014	110

Page 1